Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A survey of human leukaemias for sequences of a human retrovirus

Abstract

Human T-cell leukaemia-lymphoma virus (HTLV) is an exogenous human retrovirus distinct from all known animal retroviruses. HTLV is closely linked to a subtype of adult T-cell malignancies and except for isolated cases, has not been found associated with any other form of leukaemia, lymphoma or other cancers (see refs 1, 2 for review). HTLV can be transmitted to cord blood T lymphocytes in vitro and the infected cells exhibit characteristics of transformed neoplastic T cells3–5. We have recently cloned DNA sequences derived from approximately 1 kilobase (kb) of the 5′ and 3′ termini of the HTLV genome, as well as a 4–5-kb defective HTLV provirus flanked by cellular sequences6. The availability of these probes has enabled us to carry out a limited survey of different fresh or cultured cells from patients of different lymphoid and myeloid malignancies for HTLV-related DNA sequences. The results presented here show that cells from all Japanese patients with adult T-cell leukaemia and several patients with various mature T-cell malignancies from elsewhere contained one or more copies of a highly conserved HTLV genome. The infected cells are of clonal origin. Fresh cells from 1 of the 10 myeloid leukaemic patients contained exogenous DNA sequences distantly related to HTLV.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gallo, R. C. & Wong-Staal, F. Blood 60, 545–557 (1982).

    CAS  PubMed  Google Scholar 

  2. Gallo, R. C. et al. in Modem Trends in Human Leukemia V (ed. Neth, R.) (Springer, Munich, in the press).

  3. Miyoshi, I. et al. Nature 294, 770–771 (1982).

    Article  ADS  Google Scholar 

  4. Popovic, M. et al. Science 219, 856–859 (1983).

    Article  ADS  CAS  Google Scholar 

  5. Markham, P. D. et al. J. Virol. (submitted).

  6. Manzari, V. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).

  7. Yoshida, M., Miyoshi, I. & Hinuma, Y. Proc. natn. Acad. Sci. U.S.A. 79, 2031–2035 (1982).

    Article  ADS  CAS  Google Scholar 

  8. Saxon, A., Stevens, R. H. & Golde, D. W. Ann. intern. Med. 88, 323–326 (1978).

    Article  CAS  Google Scholar 

  9. Kalyanaraman, V. S. et al. Science 218, 571–573 (1982).

    Article  ADS  CAS  Google Scholar 

  10. Gallo, R. C. et al. Cancer Res. (submitted).

  11. Neel, B. G., Hayward, W. S., Robinson, H. L., Fang, J. & Astrin, S. M. Cell 23, 323–334 (1981).

    Article  CAS  Google Scholar 

  12. Payne, G. S., Bishop, J. M. & Varmus, H. E. Nature 295, 209–213 (1982).

    Article  ADS  CAS  Google Scholar 

  13. Kettmann, R. et al. Leukemia Res. 4, 509–519 (1981).

    Article  Google Scholar 

  14. Manzari, V. et al. Proc. natn. Acad. Sci. U.S.A. 80, 11–15 (1983).

    Article  ADS  CAS  Google Scholar 

  15. Hayward, W. S., Neel, B. G. & Astrin, S. M. in Advances in Viral Oncology Vol. 1 (ed. Klein, G.) 207–233 (Raven, New York, 1982).

    Google Scholar 

  16. Sarin, P. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong-Staal, F., Hahn, B., Manzari, V. et al. A survey of human leukaemias for sequences of a human retrovirus. Nature 302, 626–628 (1983). https://doi.org/10.1038/302626a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/302626a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing